(R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9284306
APP PUB NO 20150119431A1
SERIAL NO

14400071

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

(R)-Nifuratel is disclosed together with its use as bactericide and bacteriostatic agent as well as the pharmaceutical compositions containing the same; (R)-nifuratel has been surprisingly found to possess a better antimicrobial profile than either nifuratel racemate or (S)-nifuratel. A new procedure for the synthesis of both (R)-Nifuratel and (S)-Nifuratel is also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
POLICHEM SA50 VAL FLEURI LUXEMBOURG L-1526

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bulgheroni, Anna Varese, IT 2 0
Consonni, Alessandra Cassano Magnago, IT 3 1
Gagliardi, Stefania Vimercate, IT 44 143
Mailland, Federico Lugano, CH 37 179

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00